Breast cancer treatment resistance linked to signaling pathway

Courtesy EurekAlert! - Chemistry, Physics and Materials Sciences  Mon, 09/22/2008 - 23:00

(American Association for Cancer Research) Activation of the Src signaling pathway may cause resistance to standard medical treatment in some patients with breast cancer, and inhibition of this pathway holds the potential to overcome that resistance, according to data presented here at the American Association for Cancer Research Molecular Diagnostics in Cancer Therapeutic Development meeting.

Tags:

 

More related items

European ancestry increases breast cancer risk among...
(American Association for Cancer Research) Latina women have a lower risk of breast cancer than European or African-American women generally, but those with higher European ancestry could be...

Study links nicotine with breast cancer growth and...
(American Association for Cancer Research) A study published in Cancer Research, a journal of the American Association for Cancer Research, suggests a possible role for nicotine in breast...

Vaccine against HER2-positive breast cancer offers...
(American Association for Cancer Research) Researchers at Wayne State University have tested a breast cancer vaccine they say completely eliminated HER2-positive tumors in mice -- even...

Soapmaker's Companion: A Comprehensive Guide with...
Basic soapmaking instruction and specialty techniques like marbling, layering, and making transparent and liquid soaps.

The Black Hole War: My Battle with Stephen Hawking to...
What happens when something is sucked into a black hole? Does it disappear? Three decades ago, a young physicist named Stephen Hawking claimed it did-and in doing so put at risk everything we...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com